$NVEC

BAKER DANIEL A sold $2.3M of NVEC

BAKER DANIEL A (President & CEO) sold 20,000 shares of NVE CORP /NEW/ (NVEC) at an average of $114.91 ($114.08–$117.57, $2.30M total) across 3 trades over 2026-07-27 to 2026-07-29.

Original reporting
SEC EDGAR · BAKER DANIEL A
Published Jul 29, 2026, 11:18 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 29, 2026, 11:20 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$NVEC
Neutral
medium confidence
Mentioned
$NVEC
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NVECNeutralLow
01

Why it matters

The disclosed fact is the CEO’s open-market sale totaling about $2.30M, which may slightly affect sentiment but lacks any accompanying operational or financial update in the text.

02

Market read

Primarily a sentiment datapoint from an insider sale; without additional company catalysts, it is unlikely to drive a sustained repricing on its own.

03

What to watch

The filing does not disclose intent, tax context, or whether other insiders are buying; traders should watch for subsequent Form 4s (buys or larger sales) and any concurrent company disclosures.

Relevance 6/10Novelty 3/10Timing: filed 2026-07-29 after-hours on SEC EDGAR

Background

The article is an SEC Form 4 insider transaction for NVE Corp, listing the CEO as the reporting insider and detailing sale dates, prices, and post-transaction holdings.

Company-level read

Ticker impact

$NVECNeutralMedium confidence
Context

SEC Form 4 shows NVE Corp CEO Daniel A. Baker sold 20,000 shares in open-market trades for about $2.30M between 2026-07-27 and 2026-07-29.

Expected impact

Likely limited near-term impact; treat as modest sentiment noise unless follow-on filings or guidance changes appear.

Evidence & confidence

The filing is primary-source and time-stamped, but it is a sale (not a buy), and the article provides no accompanying company-specific catalyst such as earnings, guidance, contracts, or regulatory action.

Market effects

No sector read-through is provided beyond a single insider transaction.

None indicated.

None indicated.

Counterpoint

Insider sales can be driven by diversification, taxes, or pre-planned liquidity needs; the absence of a stated 10b5-1 plan does not necessarily imply negative information.

Key entities

  • NVE Corp

    Company whose CEO reported an open-market sale of 20,000 shares via SEC Form 4.

  • Daniel A. Baker

    President and CEO who sold shares in three trades between 2026-07-27 and 2026-07-29.

Related articles

$NVECMed

NVE (NVEC) Q1 2027 Earnings Call Transcript

NVE Corp (NVEC) Q1 2027 results showed net income up 79% to $6.39 million, or $1.32 per diluted share, on higher revenue. Operating expenses rose mainly from performance-based compensation, while expense as a % of revenue fell to 15% from 19%. Cash and marketable securities rose to $43.9 million. The company launched two MRI-safe wafer-level chip scale sensors and announced CEO succession.

$NVECMed

NVE CORP /NEW/ (NVEC): Results of Operations and Financial Condition

NVE CORP /NEW/ (NVEC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 nve_ex99z1.htm PRESS RELEASE Press Release NVE Corporation Reports First Quarter Results and Announces Quarterly Dividend Revenue increases 81% and net income increases 79% EDEN PRAIRIE, Minn.—July 22, 2026—NVE Corporation (Nasdaq: NVEC) announced today financial result